A controlled study of ticarcillin plus clavulanic acid versus piperacillin as empiric therapy for fever in the immunocompromised host
- 1 November 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (5) , 67-72
- https://doi.org/10.1016/0002-9343(85)90131-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Antibiotics in Patients With NeutropeniaArchives of internal medicine (1960), 1984
- Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other β-lactamsJournal of Antimicrobial Chemotherapy, 1984
- Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the FutureClinical Infectious Diseases, 1983
- Empiric Treatment of Infections in Neutropenic Patients with CancerClinical Infectious Diseases, 1983
- -Lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1982
- Piperacillin or ticarcillin plus amikacinThe American Journal of Medicine, 1981
- Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 1978
- Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusAntimicrobial Agents and Chemotherapy, 1977
- The β-lactamases of Gram-negative bacteria and their rôle in resistance to β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1976
- Empiric Therapy with Carbenicillin and Gentamicin for Febrile Patients with Cancer and GranulocytopeniaNew England Journal of Medicine, 1971